Cat. #151874
Anti-BCLAF1 [M33-P5B11]
Cat. #: 151874
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: BCL2 Associated Transcription Factor 1 (BCLAF1)
Class: Monoclonal
Application: IHC ; WB ; ELISA ; IHC ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Ayham Alnabulsi
Institute: Vertebrate Antibodies Limited
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-BCLAF1 [M33-P5B11]
- Research fields: Apoptosis and autophagy;Cancer;Genetics
- Clone: M33-P5B11
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: IHC ; WB ; ELISA ; IHC ; WB
- Description: BCLAF1 was associated with poor prognosis and showed aberrant localization in colorectal cancer.
- Immunogen: Peptide Sequence - KYQGDGIVED (amino acids 900 909)
- Isotype: IgG1 kappa
- Recommended controls: ELISA- Peptide immunogenWestern Blot- Hela whole cell extractIHC- Human colon carcinoma
Target Details
- Target: BCL2 Associated Transcription Factor 1 (BCLAF1)
- Tissue cell line specificity: ELISA- Peptide immunogenWestern Blot- Hela whole cell extractIHC- Human colon carcinoma
- Target background: BCLAF1 was associated with poor prognosis and showed aberrant localization in colorectal cancer.
Applications
- Application: IHC ; WB ; ELISA ; IHC ; WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
References
- Brown et al. 2016. Histopathology. 68(4):556-66. PMID: 26183150.
- The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy.
